☆ 4.6 Review

Copper Deficiency as Wilson's Disease Overtreatment: A Systematic Review

DIAGNOSTICS (2023)

Related references

Note: Only part of the references are listed.

Article Clinical Neurology

Serum neurofilament light chain and initial severity of neurological disease predict the early neurological deterioration in Wilson's disease

Tjalf Ziemssen et al.

Summary: This study analyzed the frequency and risk factors of early neurological deterioration in Wilson's disease (WD). The results showed that early deterioration is common in WD patients, particularly in the neurological phenotype. The severity of initial neurological disease and pre-treatment serum neuro-filament light chain (sNfL) concentrations were identified as significant risk factors.

ACTA NEUROLOGICA BELGICA (2023)

Add to Collection

Article Gastroenterology & Hepatology

A multidisciplinary approach to the diagnosis and management of Wilson disease: Executive summary of the 2022 Practice Guidance on Wilson disease from the American Association for the Study of Liver Diseases

Michael L. Schilsky et al.

Summary: This is an executive summary of the extensively rewritten guidance on the diagnosis and management of Wilson disease. The full guidance document can be found on the American Association for the Study of Liver Diseases (AASLD) website. The summary provides an overview and guidance statements based on evidence and expert consensus opinion.

HEPATOLOGY (2023)

Add to Collection

Article Medicine, General & Internal

Copper Deficiency in Wilson?s Disease with a Normal Zinc Value

Masayuki Ueda et al.

Summary: This article describes a case of copper deficiency in a 57-year-old female patient with Wilson's disease who had been receiving long-term treatment. The patient presented with limb weakness, sensory disturbance, and macrocytic anemia. Reduced serum free copper values confirmed the diagnosis of copper deficiency, which was attributed to progressive dysphagia and severe diarrhea rather than zinc overdose. Discontinuation of copper-reducing therapy and increased copper intake led to an improvement in symptoms. Physicians should be aware of the risk of copper deficiency in Wilson's disease patients, especially those with dysphagia.

INTERNAL MEDICINE (2023)

Add to Collection

Review Medicine, General & Internal

Monitoring of Copper in Wilson Disease

Grazyna Gromadzka et al.

Summary: Wilson's disease (WND) is a genetic disorder affecting copper metabolism. Multiple diagnostic tools are available to diagnose and monitor WND. Laboratory tests for copper metabolism disorders play a significant role in diagnosis.

DIAGNOSTICS (2023)

Add to Collection

Review Medicine, General & Internal

Blood Based Biomarkers of Central Nervous System Involvement in Wilson's Disease

Agnieszka Antos et al.

Summary: Wilson's disease is an inherited disorder of copper metabolism that can cause hepatic and/or neuropsychiatric symptoms. Early diagnosis and anti-copper treatment are key for a favorable outcome. New treatment modalities are being sought to prevent neurological deterioration. Serum biomarkers are important for disease management, and there is a need for blood-based biomarkers for central nervous system (CNS) injury.

DIAGNOSTICS (2023)

Add to Collection

Article Clinical Neurology

Serum Neurofilament Light Chain as a Biomarker of Brain Injury in Wilson's Disease: Clinical and Neuroradiological Correlations

Tjalf Ziemssen et al.

Summary: This study suggests that serum concentrations of neurofilament light chain (sNfL) may serve as a marker of brain injury in Wilson's disease and complement the clinical and neuroimaging disease severity scales.

MOVEMENT DISORDERS (2022)

Add to Collection

Article Gastroenterology & Hepatology

A multidisciplinary approach to the diagnosis and management of Wilson disease: Executive summary of the 2022 practice guidance on Wilson disease from the American Association for the Study of Liver Diseases

Michael L. L. Schilsky et al.

HEPATOLOGY (2022)

Add to Collection

Article Medicine, General & Internal

Wilson disease: copper deficiency and iatrogenic neurological complications with zinc therapy

Landy M. Wu et al.

INTERNAL MEDICINE JOURNAL (2020)

Add to Collection

Review Gastroenterology & Hepatology

Anemia following zinc treatment for Wilson's disease: a case report and literature review

Sha Cai et al.

BMC GASTROENTEROLOGY (2019)

Add to Collection

Editorial Material Medicine, General & Internal

Reversible pancytopenia caused by severe copper deficiency in a patient with Wilson disease

Muhajir Mohamed et al.

MEDICAL JOURNAL OF AUSTRALIA (2018)

Add to Collection

Article Medicine, General & Internal

Wilson disease

Anna Czlonkowska et al.

NATURE REVIEWS DISEASE PRIMERS (2018)

Add to Collection

Article Gastroenterology & Hepatology

Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study

Karl Heinz Weiss et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2017)

Add to Collection

Article Medical Laboratory Technology

The predictive value of low plasma copper and high plasma zinc in detecting zinc-induced copper deficiency

Andrew Duncan et al.

ANNALS OF CLINICAL BIOCHEMISTRY (2016)

Add to Collection

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Wilson’s disease

JOURNAL OF HEPATOLOGY (2015)

Add to Collection

Article Gastroenterology & Hepatology

Long-term Outcomes of Patients With Wilson Disease in a Large Austrian Cohort

Sandra Beinhardt et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)

Add to Collection

Article Hematology

Cytopenia and Bone Marrow Dysplasia in a Case of Wilson's Disease

Aarathi R. Rau et al.

INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION (2014)

Add to Collection

Article Clinical Neurology

Symptomatic copper deficiency in three Wilson's disease patients treated with zinc sulphate

Karolina Dziezyc et al.

NEUROLOGIA I NEUROCHIRURGIA POLSKA (2014)

Add to Collection

Letter Clinical Neurology

Recovery after copper-deficiency myeloneuropathy in Wilson's disease

Tiago Teodoro et al.

JOURNAL OF NEUROLOGY (2013)

Add to Collection

Article Clinical Neurology

Increased seizure frequency due to the copper deficiency in Wilson's disease

H. Kaleagasi et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)

Add to Collection

Article Gastroenterology & Hepatology

Myelopathy secondary to copper deficiency as a complication of treatment of Wilson's disease

Jesus Lozano Herrero et al.

GASTROENTEROLOGIA Y HEPATOLOGIA (2012)

Add to Collection

Letter Clinical Neurology

Copper Deficiency in Wilson's Disease: Peripheral Neuropathy and Myelodysplastic Syndrome Complicating Zinc Treatment

Andrea Cortese et al.

MOVEMENT DISORDERS (2011)

Add to Collection

Editorial Material Clinical Neurology

COPPER DEFICIENCY MYELONEUROPATHY IN A PATIENT WITH WILSON DISEASE

F. P. da Silva-Junior et al.

NEUROLOGY (2011)

Add to Collection

Review Clinical Neurology

Copper deficiency myelopathy

Stephan R. Jaiser et al.

JOURNAL OF NEUROLOGY (2010)

Add to Collection

Letter Clinical Neurology

Zinc-induced copper deficiency in Wilson disease

J. Horvath et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2010)

Add to Collection

Article Clinical Neurology

Partial status epilepticus induced by hypocupremia in a patient with Wilson's disease

Gulcin Benbir et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2010)

Add to Collection

Article Medicine, General & Internal

The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

Alessandro Liberati et al.

ANNALS OF INTERNAL MEDICINE (2009)

Add to Collection

Article Gastroenterology & Hepatology

Long-Term Exclusive Zinc Monotherapy in Symptomatic Wilson Disease: Experience in 17 Patients

Francisca H. H. Linn et al.

HEPATOLOGY (2009)

Add to Collection

Article Clinical Neurology

AXONAL SENSORY MOTOR NEUROPATHY IN COPPER-DEFICIENT WILSON'S DISEASE

Alexandra Foubert-Samier et al.

MUSCLE & NERVE (2009)

Add to Collection

Article Clinical Neurology

Treatment of Wilson disease with ammonium tetrathiomolybdate - IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease

GJ Brewer et al.

ARCHIVES OF NEUROLOGY (2006)

Add to Collection

Article Clinical Neurology

Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration

N Kumar et al.

NEUROLOGY (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.